Recent Finacing
Recent Raise
RetroSense Therapeutics develops RST-001, an optogenetic gene therapy to confer light sensitivity in degenerated retinas for retinitis pigmentosa and dry AMD, holding exclusive IP from Wayne State and MGH.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors